[Hiring] Director, Medical Communications & Congress Strategy @Syndax Pharmaceuticals

Role Description

The Director, Medical Communications & Congress Strategy is responsible for leading the development and execution of integrated medical communications and scientific engagement strategies across marketed products and pipeline programs. This role drives multichannel healthcare professional engagement, oversees medical congress and sponsored education initiatives, and ensures the delivery of high-quality, compliant scientific content that supports Medical Affairs objectives. Working closely with cross-functional stakeholders including Medical Strategy, Publications, Medical Information, Field Medical, Regulatory, Legal, and Compliance, the Director establishes communication priorities, manages budgets and vendor partnerships, and leverages performance metrics to optimize scientific exchange, customer engagement, and overall medical impact.

Key Responsibilities

• Lead strategic Medical Communications by partnering with Medical Strategy, Publications, and Medical Information to develop and execute integrated medical communication strategies across commercial products and pipeline programs.
• Lead the development of multichannel, peer-to-peer web-based and other HCP engagement strategies while ensuring scientific accuracy, objectivity, fair-balance, and alignment with internal medical communications plans.
• Support integration of new assets, products, or therapeutic areas into medical communications platforms, including development of disease-state, pipeline, clinical trial, congress, publication, and mechanism-of-action content.
• Lead planning and execution for medical congress presence, including communication objectives, exhibit booth strategy, vendor coordination, logistics, booth staffing, asset development, and post-congress follow-up.
• Lead planning and execution of sponsored medical education alongside omnichannel scientific communications, acting as liaison to medical education vendors for sponsored content and digital amplification of company data.
• Support Medical Information and Field Medical content development by providing scientific content strategy, therapeutic area context, and alignment with broader Medical Communications plans to inform response development and resource prioritization.
• Develop the annual tactical plan and budget for Medical Communications activities; manage Medical Communications vendor, contracts, and invoicing.
• Develop, monitor, and communicate metrics and KPIs that demonstrate the impact of Medical Communications on scientific engagement, customer experience, organizational priorities, and Medical Affairs strategy.
• Ensure medical education initiatives meet governance, legal, compliance, and regulatory standards.

Qualifications

• Advance degree (PharmD, PhD, MD or equivalent).
• 8+ years of progressive Medical Affairs experience, including Medical Communications and Medical Information leadership responsibilities.
• Demonstrated ability to develop and implement strategic medical communications.
• Experience with digital medical communications platforms, content management systems, and multichannel engagement strategies.
• Experience in Medical Information operations, inquiry management, and compliant scientific exchange.
• Vendor management including performance, quality, and budget oversight.
• In-depth knowledge of Medical Affairs ethics and compliance environment.
• Travel expectations: approximately 20%, domestic and international.

Location

Syndax’s corporate office is in New York, NY.

Benefits

• Competitive total compensation and rewards package.
• Base pay determined within a range based on several factors including market data, experience, qualifications, demonstrated skills, relevant education or training, travel requirements, and internal equity.
• Equity offering and annual target bonuses.
• Outstanding benefits program.
• Anticipated annualized salary range for this role is $220,000 - $245,000.

Company Description

Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company advancing innovative cancer therapies. Highlights of the Company’s pipeline include a menin inhibitor for R/R acute leukemia and a monoclonal antibody that blocks the CSF-1 receptor for chronic graft-versus-host disease. Fueled by our commitment to reimagining cancer care, Syndax is working to unlock the full potential of its pipeline and is conducting several clinical trials across the continuum of treatment.

For more information, please visit www.syndax.com or follow the Company on X and LinkedIn .

Syndax Pharmaceuticals is an equal opportunity employer and will not discriminate against any employee or applicant on the basis of age, color, disability, gender, national origin, race, religion, sexual orientation, veteran status, or any classification protected by federal, state, or local law.